Search by Drug Name or NDC

    NDC 12496-0757-05 Buprenex 0.3 mg/mL Details

    Buprenex 0.3 mg/mL

    Buprenex is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Indivior Inc.. The primary component is BUPRENORPHINE HYDROCHLORIDE.

    Product Information

    NDC 12496-0757
    Product ID 12496-0757_9925737b-3031-4372-a2cf-8c4ed05ebdbf
    Associated GPIs 65200010102005
    GCN Sequence Number 004262
    GCN Sequence Number Description buprenorphine HCl AMPUL 0.3 MG/ML INJECTION
    HIC3 H3A
    HIC3 Description OPIOID ANALGESICS
    GCN 27500
    HICL Sequence Number 001762
    HICL Sequence Number Description BUPRENORPHINE HCL
    Brand/Generic Brand
    Proprietary Name Buprenex
    Proprietary Name Suffix n/a
    Non-Proprietary Name buprenorphine hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 0.3
    Active Ingredient Units mg/mL
    Substance Name BUPRENORPHINE HYDROCHLORIDE
    Labeler Name Indivior Inc.
    Pharmaceutical Class Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
    DEA Schedule CIII
    Marketing Category NDA
    Application Number NDA018401
    Listing Certified Through 2023-12-31

    Package

    NDC 12496-0757-05 (12496075705)

    NDC Package Code 12496-0757-5
    Billing NDC 12496075705
    Package 5 AMPULE in 1 CARTON (12496-0757-5) / 1 mL in 1 AMPULE (12496-0757-1)
    Marketing Start Date 1985-06-30
    NDC Exclude Flag N
    Pricing Information N/A